A Study of JNJ-64530440 in Healthy Japanese Male Participants

NCT03915886 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Stopped due to a strategic decision.

Conditions

Healthy

Interventions

DRUG: JNJ-0440
DRUG: Placebo

Sponsor

Janssen Pharmaceutical K.K.

Collaborators

[object Object]